These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7229980)

  • 1. Anticonvulsant toxicity in vitro: possible role of arene oxides.
    Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS
    J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid in vitro assay for evaluation of metabolism-dependent cytotoxicity of antiepileptic drugs on isolated human lymphocytes.
    Tabatabaei AR; Thies RL; Farrell K; Abbott FS
    Fundam Appl Toxicol; 1997 Jun; 37(2):181-9. PubMed ID: 9242591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetaminophen toxicity in human lymphocytes in vitro.
    Spielberg SP
    J Pharmacol Exp Ther; 1980 May; 213(2):395-8. PubMed ID: 7365697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism.
    Spielberg SP; Gordon GB
    J Clin Invest; 1981 Jan; 67(1):37-41. PubMed ID: 7451657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
    Gordon GB; Spielberg SP; Blake DA; Balasubramanian V
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2545-8. PubMed ID: 6941308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro lymphocyte toxicity to a phenytoin metabolite in phenytoin induced cutaneous adverse drug eruptions.
    Dwivedi R; Gogtay N; Kharkar V; Amladi S; Kshirsagar N
    Indian J Dermatol Venereol Leprol; 2004; 70(4):217-20. PubMed ID: 17642618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen.
    Hinson JA; Pohl LR; Monks TJ; Gillette JR; Guengerich FP
    Drug Metab Dispos; 1980; 8(5):289-94. PubMed ID: 6107223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility.
    Kearns GL; Wheeler JG; Childress SH; Letzig LG
    J Pediatr; 1994 Nov; 125(5 Pt 1):805-11. PubMed ID: 7965438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
    Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems.
    Fontaine SM; Mash EA; Hoyer PB; Sipes IG
    Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary.
    Keller DA; Carpenter SC; Cagen SZ; Reitman FA
    Toxicol Appl Pharmacol; 1997 May; 144(1):36-44. PubMed ID: 9169067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of a toxic metabolite of sulfadiazine.
    Shear NH; Spielberg SP
    Can J Physiol Pharmacol; 1985 Nov; 63(11):1370-2. PubMed ID: 4075255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans.
    Spielberg SP
    Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pulmonary benzo(a)pyrene 4,5-oxide clearance: a pharmacokinetic analysis of epoxide-metabolizing enzymes in rabbit lung.
    Smith BR; Bend JR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):478-82. PubMed ID: 7190605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of drug-induced toxicity in the mouse lymphoma assay by a rat hepatic microsomal metabolizing system (S-9).
    Oldham JW; Preston RF; Paulson JD; Pritchard JF
    J Appl Toxicol; 1984 Jun; 4(3):124-30. PubMed ID: 6235269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of modulators of epoxide metabolism on the cytotoxicity of trans-anethole in freshly isolated rat hepatocytes.
    Marshall AD; Caldwell J
    Food Chem Toxicol; 1992 Jun; 30(6):467-73. PubMed ID: 1500033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
    Martz F; Failinger C; Blake DA
    J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.